Pharmacovigilance analysis of cardiac risks associated with Bruton tyrosine kinase inhibitors.
Expert Opin Drug Saf
; 22(9): 857-869, 2023.
Article
in En
| MEDLINE
| ID: mdl-37070462
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Atrial Fibrillation
/
Heart Diseases
Type of study:
Etiology_studies
/
Risk_factors_studies
Limits:
Humans
Language:
En
Journal:
Expert Opin Drug Saf
Journal subject:
FARMACOLOGIA
/
TERAPIA POR MEDICAMENTOS
Year:
2023
Type:
Article
Affiliation country:
China